FDA Approves SPRAVATO (esketamine) as First and Only Monotherapy for Treatment-Resistant Depression in Adults Read more
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe Read more
Dyne Therapeutics’ DYNE-101 Granted FDA Fast Track Designation for Myotonic Dystrophy Type 1 Read more
Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S. Read more
Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company Read more
REGENXBIO and Nippon Shinyaku Form Exclusive Partnership to Develop RGX-121 and RGX-111 for MPS Diseases Read more